MedTwenty News

Daily stories

One verified UK healthcare business story each weekday: what happened, why it matters and the source.

All subjects NHS & Healthcare Finance Healthcare Companies Healthcare Technology Regulation & Policy Investment & Markets

Everything Stories The Brief Analysis

All regions UK US Global

Healthcare Technology

MHRA Unveils New Regulatory Framework for In Vitro Diagnostics, Promising Greater Agility

The Medicines and Healthcare products Regulatory Agency (MHRA) has published its updated regulatory framework for In Vitro Diagnostic (IVD) medical devices, aimed at streamlining approvals and enhancing post-market surveillance. The move is designed to support innovation while maintaining high safety standards.

Priya Nair·7 min read·2 Sept 2026, 09:00

Healthcare Technology

Precision Medicine Sector Sees European Funding Surge Amidst Regulatory Harmonisation Hopes

Investment in European precision medicine ventures has markedly increased in Q3 2026, driven by anticipated advancements in EU data and regulatory frameworks. Biotech firms focusing on gene therapy and biomarker diagnostics are attracting significant capital.

Priya Nair·7 min read·2 Sept 2026, 09:00

Healthcare Technology

NIHR Launches National Digital Health Research Hubs to Accelerate Innovation and NHS Adoption

The National Institute for Health and Care Research (NIHR) has unveiled plans for five new national digital health research hubs across the UK, backed by a £150 million investment. The initiative aims to foster collaboration between academia, industry, and the NHS to accelerate the development and deployment of digital health solutions.

S. Adeyemi·8 min read·30 Aug 2026, 09:00

Healthcare Technology

AI Imaging Solutions Prove Crucial in Addressing NHS Radiology Backlogs, Study Finds

A new independent review highlights the significant impact of advanced AI imaging platforms in reducing diagnostic backlogs across NHS trusts. Early data indicates a 25% improvement in reporting efficiency for certain modalities, alleviating pressure on overstretched radiology departments.

Helen Carter·6 min read·28 Aug 2026, 09:00

Regulation & Policy

NHS Unveils Winter Plan 2026 Amid Intensifying Staffing Crisis Concerns

The National Health Service has detailed its strategy for the upcoming winter period, emphasising system resilience and accelerated patient flow. The plan, however, faces scrutiny from unions and healthcare leaders regarding its capacity to address deep-seated workforce shortages.

PremiumJames Whitfield·7 min read·28 Aug 2026, 09:00

Regulation & Policy

NHS Intensifies Global Recruitment Efforts to Address Deepening Workforce Shortages

The NHS has launched an aggressive new international recruitment campaign, targeting nurses and doctors from Commonwealth nations amidst record staff vacancies. The move comes as domestic training pipelines struggle to keep pace with demand.

PremiumHelen Carter·7 min read·28 Aug 2026, 09:00

Healthcare Technology

AstraZeneca Advances Oral Obesity Drug into Phase 3, Signalling Intensified Competition

AstraZeneca has announced its oral GLP-1 receptor agonist, AZN-789, has entered Phase 3 trials, intensifying the race for market share in the burgeoning obesity treatment landscape. The move positions the Anglo-Swedish pharmaceutical giant as a significant challenger to established players.

Oruaro Onibere·7 min read·27 Aug 2026, 09:00

Healthcare Technology

Patient Data Sharing Initiative Launches Across England Pilot, Raising Privacy Questions

A new NHS England-led initiative to facilitate secure, real-time sharing of patient data across primary, secondary, and social care settings has commenced its pilot phase. Proponents hail it as a crucial step towards integrated care, but privacy advocates raise concerns about consent mechanisms and data security.

Oruaro Onibere·7 min read·25 Aug 2026, 09:00

Investment & Markets

Private Equity Firms Drive Biotech M&A Surge, Focusing on Strategic Repositioning

Private equity (PE) firms are increasingly active in the biotech M&A landscape, moving beyond traditional buyouts to strategic repositioning of assets. This trend is reshaping the competitive dynamics of the pharmaceutical industry.

Oruaro Onibere·7 min read·25 Aug 2026, 09:00

Showing 31–39 of 39 pieces